239 results
Page 4 of 12
6-K
EX-99
nnv6 z8eh6
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
40h9rn imnef6x1bm6
27 May 20
BioLineRx Announces Publication of Data from Ongoing
7:00am
6-K
EX-99
pnp1t
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
nyyiht
12 Mar 20
BioLineRx Reports Year-End 2019 Financial Results
7:00am
6-K
EX-99
90wk7
27 Feb 20
BioLineRx Announces Notice of Allowance from USPTO for Patent Covering Motixafortide (BL-8040) in Combination with The COMBAT/KEYNOTE-202 Study
7:00am
6-K
EX-99
xrsg59azyfo
22 Jan 20
BioLineRx Completes Recruitment in Triple Combination
7:00am
6-K
EX-99
zdzaynsp72ads6j rrc
13 Dec 19
BioLineRx Announces Updated Phase 2a Data from Triple
7:00am
6-K
EX-99
27o9fu7mxmfe tfl94r3
5 Dec 19
BioLineRx Announces Preliminary Phase 2a Data from Triple
7:00am
6-K
EX-3
c03o u49hxbolpir4
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-1
hutnnk2z
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-99
816mn2z5
25 Sep 19
BioLineRx Announces Dosing of First Patient in Part 2 of
7:00am
6-K
EX-99
5azzuthxn 4mo44w
3 Sep 19
BioLineRx Successfully Completes Dose-Escalation Part of
7:00am
6-K
EX-99
eskfqw4 x6
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-99
05bx1du
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-99
qg3ffd9whfo5x 2k3plq
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
tpgdx9usqp7x69
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-1
3h9i hlwne1g
7 May 19
Current report (foreign)
7:00am
6-K
EX-99
03jucjx5lzqm915
28 Mar 19
BioLineRx Reports Year End 2018 Financial Results
7:00am